tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Ipsen (GB:0MH6)
LSE:0MH6
0MH6
Ipsen
Stock Analysis
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding GB:0MH6?
Track your performance easily
Link Broker

Ipsen (0MH6) Stock News & Sentiment

3 Followers
Ipsen’s New PBC Treatment Iqirvo Gains EU Approval
Premium
Company Announcements
Ipsen’s New PBC Treatment Iqirvo Gains EU Approval
1m ago
Ipsen Nears EU Approval for Liver Disease Drugs
Premium
Company Announcements
Ipsen Nears EU Approval for Liver Disease Drugs
2M ago
Ipsen Secures Deal for Promising Cancer Drug FS001
Premium
Company Announcements
Ipsen Secures Deal for Promising Cancer Drug FS001
2M ago
Ipsen Eyes Expanded Market for Cabometyx After Trial Success
Premium
Company Announcements
Ipsen Eyes Expanded Market for Cabometyx After Trial Success
3M ago
Ipsen’s Iqirvo® Wins FDA Nod for Liver Disease
Premium
Company Announcements
Ipsen’s Iqirvo® Wins FDA Nod for Liver Disease
3M ago
Ipsen Bolsters Oncology Research with Marengo
Premium
Company Announcements
Ipsen Bolsters Oncology Research with Marengo
4M ago
Ipsen Welcomes New EVP of Corporate Affairs
Premium
Company Announcements
Ipsen Welcomes New EVP of Corporate Affairs
4M ago
More GB:0MH6 News >

0MH6 News on the Web

Ipsen (0MH6) Receives a Buy from Kepler Capital
TipRanks News
Bullish
Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
Yahoo Finance
Neutral
Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
Yahoo Finance UK
Neutral
Ipsen’s Market Outlook: Hold Rating Amidst Mixed Product Developments
TipRanks News
Bullish
Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis
Yahoo Finance
Neutral
Ipsen provides update on CONTACT-02 Phase III trial in metastatic castration-resistant prostate cancer following final overall survival analysis
Yahoo Finance UK
Neutral
These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well
Simply Wall St
Neutral
Ipsen - August 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
Yahoo Finance UK
Neutral

News Score - Last 7 Days

Positive
GB:0MH6
Sector Average
Media Buzz
This Week6 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0MH6’s Media Buzz Sentiment?
6 articles about GB:0MH6 were published this week. In an average week, 2 articles are published.
    What is GB:0MH6’s weekly average amount of articles?
    In an average week, 2 articles about GB:0MH6 are published.
      What is GB:0MH6’s News Sentiment?
      100% of articles about GB:0MH6 were positive this week, compared to its sector average of 60%.
        Healthcare Stocks that are Trending in the News
        NUVLNuvalent
        EWTXEdgewise Therapeutics
        BLCOBausch + Lomb Corporation
        INCYIncyte
        ACRVAcrivon Therapeutics, Inc.
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing